Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Canakinumab's effect on COVID-19 outcomes is unclear.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Certain medications can cause serious side effects, so it's important to report them.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Co-trimoxazole may help treat autoimmune diseases.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.